Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

Carmen Rapp, Steffen Dettling, Fang Liu, Anna Theresa Ull, Rolf Warta, Christine Jungk, Saskia Roesch, Andreas Möck, Felix Sahm, Melissa Schmidt, Gerhard Jungwirth, Klaus Zweckberger, Katrin Lamszus, Konstaninos Gousias, Almuth F. Keßler, Niels Grabe, Mario Loehr, Ralf Ketter, Steffi Urbschat, Christian Senft, Manfred Westphal, Amir Abdollahi, Jürgen Debus, Andreas von Deimling, Andreas Unterberg, Matthias Simon, Christel Herold‐MendeClinical 2019 · DOI

Abstract

We identified higher numbers of CD3<sup>+</sup>CD8<sup>+</sup>FOXP3<sup>-</sup> TILs and proportions of PD-1-expressing CD3<sup>+</sup>CD8<sup>+</sup>FOXP3<sup>-</sup> TILs as novel biomarkers for better survival. These findings might facilitate the selection of patients who may benefit from immunotherapy and argue in favor of an intervention in primary rather than recurrent tumors.
BibTeX
@inproceedings{rapp2019cytotoxic,
  author = {Carmen Rapp and Steffen Dettling and Fang Liu and Anna Theresa Ull and Rolf Warta and Christine Jungk and Saskia Roesch and Andreas Möck and Felix Sahm and Melissa Schmidt and Gerhard Jungwirth and Klaus Zweckberger and Katrin Lamszus and Konstaninos Gousias and Almuth F. Keßler and Niels Grabe and Mario Loehr and Ralf Ketter and Steffi Urbschat and Christian Senft and Manfred Westphal and Amir Abdollahi and Jürgen Debus and Andreas von Deimling and Andreas Unterberg and Matthias Simon and Christel Herold‐Mende},
  title = {{Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas}},
  booktitle = {Clinical},
  year = {2019},
  doi = {10.1158/1078-0432.ccr-19-0389},
}

Loading related content...

Figure